NCT05722652 (CONFIDENCE) is a NA clinical trial of CONFIDENCE in COVID-19 Vaccination, sponsored by University of Massachusetts, Worcester.

Who is sponsoring NCT05722652?

NCT05722652 is sponsored by University of Massachusetts, Worcester.

What drugs are being tested in NCT05722652?

Interventions in NCT05722652: CONFIDENCE.

What condition does NCT05722652 study?

NCT05722652 studies COVID-19 Vaccination.

Is NCT05722652 still recruiting?

NCT05722652 is currently completed. Last updated 14 January 2025.

Last reviewed 2025-01-14 · How we verify

NCT05722652: CONFIDENCE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents

Completed NA Last updated 14 January 2025

What this trial tests

NA trial testing CONFIDENCE in COVID-19 Vaccination in 667 participants. Completed in 31 October 2024.

Timeline

27 March 2023

Primary endpoint
31 October 2024

31 October 2024

Quick facts

Lead sponsor	University of Massachusetts, Worcester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	667
Start date	27 March 2023
Primary completion	31 October 2024
Estimated completion	31 October 2024
Sites	1 location across United States

Drugs / interventions tested

CONFIDENCE

Conditions studied

COVID-19 Vaccination — all drugs for COVID-19 Vaccination →

Sponsor

University of Massachusetts, Worcester

Who can join

18 and older, any sex, with COVID-19 Vaccination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to refine and test CONFIDENCE, a multi-component clinic-based intervention in pediatric or family practice clinical settings. Using a randomized control trial design, the investigators will assess preliminary effectiveness of the intervention to increase COVID-19 vaccine intention among parents of under-vaccinated children ages 5 to 17. Participating clinics will receive a brief intervention consisting of: (1) webinar training focused on communication with vaccine-hesitant parents, (2) parent-facing educational materials about COVID-19 vaccination, (3) support to create a personalized, poster campaign featuring providers. Clinics in the control condition will receive the intervention approximately 12 months after the clinics in the intervention condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COVID-19 Vaccination

Currently open trials in the same condition.

NCT06923137 — A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much · active not recruiting
NCT06613984 — Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran) · active not recruiting
NCT06156254 — Community Care Intervention to Decrease COVID-19 Vaccination Inequities · NA · recruiting
NCT04967807 — Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) · NA · active not recruiting
NCT04980560 — Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts · active not recruiting

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05722652 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
Last refreshed: 14 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05722652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing